期刊文献+

济南市无偿献血人群血液检测结果分析 被引量:13

Analysis of blood test results among volunteer donors in Jinna city
下载PDF
导出
摘要 目的分析济南市无偿献血人群血液检测结果。方法对2001年至2007年10月所采集全部无偿献血者的血液样本采用双人、双试剂进行ALT、HBsAg、抗-HCV、抗-HIV、梅毒抗体和不规则抗休的初检和复检。抗-HIV不合格者均经山东省疾病控制中心HIV确证实验室确认。结果历年来无偿献血者的血液检测结果总不合格率平均为5.77%,且总体呈下降趋势。ALT、HBsAg两项为不合格最主要原因。在不合格项中,不规则抗体确有一定发生率。结论应继续加强无偿献血宣传,建议开展采血前HBsAg与ALT快速检测,有条件血站对献血者进行不规则抗体筛选。 Objective To lnvestigate and analyze the blood test results of volunteer donors in Jinan City.Method All samples,collected from 2001 to October,2007,were tested and retested by two people and two reasents respectively in terms of ALT,HBsAg,anti-HCY anti-HIV,anti-syphilis,and irregular antibodies.Those with disqualifled anti-HIV were confirmed by HIV Confirmation Lab at Center for Disease Prevention and Control of Shandong Province.Result The general rate of unqualifled blood samples from volunteer donors is 5.77% and shows a downward trend.Primary reasons include disqualifled ALT and HBsAg.Incidence of irregular antibodies is detected,too.Conclusing Rapid HBsAg and ALT detection prevlous to blood collection are suggested.In addition,donors should be screened for irregular antibodies if possible.
作者 王雪 徐凌中
出处 《医学检验与临床》 2008年第1期17-18,共2页 Medical Laboratory Science and Clinics
关键词 无偿献血 检测 volunteer donors test
  • 相关文献

参考文献3

二级参考文献18

  • 1Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non- responders to interferon monotherapy: a meta- analysis of individual patient data[ J ]. Gut, 2002,51:864-869.
  • 2Papatheodoridis GV, Papadimitropoulos VC, Hsdziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus- reated cirrhosis: a meta- analysis[J] .Aliment Pnarmaool Ther, 2001,15:689- 698.
  • 3Kjaergard LL, Krogsgaard K, Gluud C. Interfern alfa with or without ribavirin for chronic hepatitis C: systematic review of randonmised trials[J].BMJ, 2001,323:1151 - 1155.
  • 4Alberti A, Benvegnu L. Management of hepatitis[J] .J Hepatol, 2003,38(Suppl1): S1014 - S1 18.
  • 5Poynard T, MdHutchison J, Davis GL, et al. Impact of interferon alfa - 2b and ribavirin on progression of liver fibrosiis in patients with chronic hepatitis C[J].Hepatology, 2000,32:1131 - 1137.
  • 6Booth JCL, O' Grady J, Neuberger J. Clinical guidelines on the mangement of hepatitis C[J]. Gut, 2001, 49(Suppl I ): il - i12.
  • 7Chander G, Sulkowski MS, Jenckes MW, et al. Treatment of chronic hepatitis C: a systemic review[J]. Hepatology, 2002, 36(5 Suppl 1 ):S135 - S144.
  • 8Di Ciomm no V, Russo P, Rava L, etal. Interferon alpha in the treatment of chronic hepatitis C in children: a mmeta- analysis[J] .J Viral Hepat,2003,10:210 - 214.
  • 9Fabrizi F, Dulai G, DixitV, et al. Meta- analysis: interfeorn for the treatment of chronic hepatitis C in dialysis patients[J] .Aliment Phamacol Ther, 2003,18:1071 - 1081.
  • 10National Institute of Health Consensus Development Conference Panel Statenent. Management of hepatitis C[J].Hepatology, 2002,36(5 Suppl 1):S3- S20.

共引文献807

同被引文献73

引证文献13

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部